Quality of life of carpal tunnel syndrome with non operative treatment: cohort study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20202886Keywords:
Carpal tunnel syndrome, Non operative treatment, Quality of lifeAbstract
Background: Carpal tunnel syndrome (CTS) is the most common peripheral neuropathy entrapment and it interferes with the quality of life. Treatment for CTS can be divided into operative and non-operative treatment. Our objective was to compare the quality of life and pain intensity in a patient with CTS after oral treatment and local corticosteroid injection (LCI).
Methods: A prospective cohort study was conducted in 18-65 years patients with CTS. Primary outcome was to compare the quality of life post oral treatment (NSAIDs, oral steroids, gabapentin) and LCI using the Short Form-36 questionnaire. Secondary output was to compare pain intensity using Numeric Rating Scale (NRS). Mann-Whitney and independent t-test were used to assess the comparison between the treatment.
Results: Sixty CTS patients were included in this study, with 32 patients (53.33%) assigned to LCI. After observation one month, statistical analysis showed that LCI improved the quality of life better than oral in physical function and bodily pain components (p = 0.036 and p = 0.047). Injection treatment decreased pain intensity more than oral not statistically significant after 14 days (p=0.087), but was significant after one month (p=0.002).
Conclusions: Local corticosteroid injection improved quality of life and decreased pain intensity better than oral treatment after one month.
References
Ibrahim I, Khan W, Goddard N, Smitham P. Carpal Tunnel Syndrome: a review of the recent literature. Open Orthopaed J. 2012;6:69-76.
Ghasemi-rad M. A handy review of carpal tunnel syndrome: From anatomy to diagnosis and treatment. World J Radiol. 2014;6(6):284.
Wolska J, Wolski D, Bienko M, Radzki R. life quality of patients with carpal tunnel syndrome. Eur J Clin Exp Med. 2018;16(3):217-23.
Wipperman J, Goerl K. Carpal Tunnel Syndrome: Diagnosis and Management. Am Fam Physician. 2016;94(12):993-9.
Waldman SD, editor. Pain management. Edisi ke-2. Philadelphia: Elsevier/Saunders; 2011.
Kurniawan S. Buku ajar saraf perifer. Edisi pertama. Malang: Universitas Brawijaya Press. 2012.
Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. 2008. Available at: http://www.thecochranelibrary.com. Accessed 20 December 2019.
Gurcay E, Unlu E, Gurcay A, Tuncay R, Cakci A. Evaluation of the effect of local corticosteroid injection and anti-inflammatory medication in carpal tunnel syndrome. Scott Med J. 2009;54(1):4-6.
Erdemoglu AK. The efficacy and safety of gabapentin in carpal tunnel patients: Open label trial. Neurol India. 2009;57(3):300.
Padua L, Coraci D, Erra C, Pazzaglia C, Paolasso I, Loreti C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016 Nov;15(12):1273-84.
Wolny T, Linek P, Saulicz E. Overall health status in patients with mild to moderate carpal tunnel syndrome: A case-control study. J Hand Ther. 2017;30(3):293-8.
Jarvik JG, Comstock BA, Kliot M, Turner JA, Chan L, Heagerty PJ, et al. Surgery versus non-surgical therapy for carpal tunnel syndrome: a randomised parallel-group trial. Lancet. 2009;374(9695):1074-81.
Celiker R, Arslan S, Inanici F. Corticosteroid injection vs. nonsteroidal antiinflammatory drug and splinting in carpal tunnel syndrome. Am J Phys Med Rehabil. 2002;81(3):182-6.
Chang MH, Ger LP, Hsieh PF, Huang SY. A randomised clinical trial of oral steroids in the treatment of carpal tunnel syndrome: a long term follow up. J Neurol, Neurosurg Psychiatry. 2002 Dec 1;73(6):710-4.
Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A. The Efficacy of 100 and 300 mg Gabapentin in the Treatment of Carpal Tunnel Syndrome. Iran J Pharm Res IJPR. 2015;14(4):1275-80.
Wong SM, Hui AC, Tang A, Ho PC, Hung LK, Wong KS, et al. Local vs systemic corticosteroids in the treatment of carpal tunnel syndrome. Neurol. 2001;56(11):1565-7.
Katz JN, Keller RB, Simmons BP, Rogers WD, Bessette L, Fossel AH, et al. Maine carpal tunnel study: Outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort. J Hand Surg. 1998;23(4):697-710.
Lawry GV, Kreder HJ, Hawker G, Jerome D. Fam’s Musculoskeletal Examination and Joint Injection Techniques: Expert Consult. London: Elsevier Health Sciences; 2010.
Türck D, Busch U, Heinzel G, Narjes H. Clinical pharmacokinetics of meloxicam. Arzneimittel Forschung. 1997;47(3):253-8.
Tacca M, Colucci R, Fornai M, Blandizzi C. Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug. Clin Drug Invest. 2002;22(12):799-818.
Brunton LL, Knollmann BC, Hilal-Dandan R, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. Thirteenth edition. New York: McGraw Hill Medical; 2018.
Herskovitz S, Berger AR, Lipton RB. Low-dose, short-term oral prednisone in the treatment of carpal tunnel syndrome. Neurol. 1995;45(10):1923-5.
